A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2019
Price : $35 *
At a glance
- Drugs Carmustine (Primary) ; Cytarabine (Primary) ; Etoposide (Primary) ; Melphalan (Primary) ; Romidepsin (Primary)
- Indications T-cell lymphoma
- Focus Therapeutic Use
- Sponsors Memorial Sloan-Kettering Cancer Center
- 06 Nov 2019 Results released at the 61st Annual Meeting and Exposition of the American Society of Hematology.
- 22 Jul 2019 Planned number of patients changed from 33 to 34.
- 01 Aug 2018 Planned End Date changed from 1 Jul 2018 to 1 Jul 2020.